Saturday - February 28, 2026
Blackstone Life Sciences Announces a Co-funding Agreement for Acute Myeloid Leukemia
February 23, 2026
NEW YORK, Feb. 23 [Category: BizFinancial Services] -- Blackstone, an investment firm, posted the following news release:

* * *

Blackstone Life Sciences Announces a Co-funding Agreement for Acute Myeloid Leukemia

*

Cambridge, MA - February 23, 2026 -Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical development of bleximenib (JNJ-75276617), an investigational oral men . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products